Sign In
Buy AMGN
$338.22
+9.96 (+3.03%)
At Close: Jun 03, 2026
5 Blue-Chip Stocks Likely to Gain on Earnings Results This Week
10:18am, Monday, 25'th Apr 2022 Zacks Investment Research
Five Dow stocks with positive Earnings ESP will report earnings results this week. These are: V, Ko, MRK, CVX and AMGN.
Why Amgen (AMGN) Might Surprise This Earnings Season
09:47am, Monday, 25'th Apr 2022
Amgen (AMGN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
5 Blue-Chip Stocks Likely to Gain on Earnings Results This Week
07:32am, Monday, 25'th Apr 2022
Five Dow stocks with positive Earnings ESP will report earnings results this week. These are: V, Ko, MRK, CVX and AMGN.
Down More Than 23%, This Year's 2 Worst-Performing Dow Stocks Look Like Monster Buys Right Now
02:53pm, Saturday, 23'rd Apr 2022 The Motley Fool
Investors have a rare opportunity to buy Nike and Home Depot on sale.
This Unstoppable Dividend Aristocrat Is 2022's Best-Performing Dow Stock (and It's Not Even Close)
12:56pm, Saturday, 23'rd Apr 2022 The Motley Fool
Chevron stock is a buy despite being up big for the year.
AMGEN ANNOUNCES WEBCAST OF 2022 FIRST QUARTER FINANCIAL RESULTS
04:00pm, Friday, 22'nd Apr 2022
THOUSAND OAKS, Calif. , April 22, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its first quarter financial results on Wednesday, April 27, 2022, after the close of the
The Smartest Dividend Stocks to Buy With $400 Right Now
11:50am, Friday, 22'nd Apr 2022 The Motley Fool
Set yourself up to collect a little extra cash while waiting for the market to figure out where it wants to go next.
Is a Beat Likely for Amgen (AMGN) This Earnings Season?
11:17am, Friday, 22'nd Apr 2022
Volume growth from Amgen's (AMGN) key drugs like Prolia, Xgeva, Repatha, and others and the biosimilars portfolio is expected to have been partially offset by biosimilar/generic competition for mature
The Smartest Dividend Stocks to Buy With $400 Right Now
07:50am, Friday, 22'nd Apr 2022
Set yourself up to collect a little extra cash while waiting for the market to figure out where it wants to go next.
Amgen (AMGN) Gains As Market Dips: What You Should Know
10:00pm, Thursday, 21'st Apr 2022 Zacks Investment Research
Amgen (AMGN) closed at $255.46 in the latest trading session, marking a +0.03% move from the prior day.
Why 5 of Warren Buffett's Highest-Yielding Stocks May Be the Best 2022 Ideas Now
07:16am, Thursday, 21'st Apr 2022
If any investor has stood the test of time, it is Warren Buffett, and with good reason.
Can Amgen (AMGN) Keep the Earnings Surprise Streak Alive?
04:10pm, Wednesday, 20'th Apr 2022 Zacks Investment Research
Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Can Amgen (AMGN) Keep the Earnings Surprise Streak Alive?
01:32pm, Wednesday, 20'th Apr 2022
Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Glaxo's (GSK) NDA for Daprodustat Gets Accepted by the FDA
12:23pm, Wednesday, 20'th Apr 2022 Zacks Investment Research
Glaxo's (GSK) NDA for daprodustat is based on data from the ASCEND phase III program comprising five studies. All the studies meet their primary efficacy and safety endpoints.
Amgen's Cancer Portfolio And Pipeline Make It A Buy
02:12am, Wednesday, 20'th Apr 2022
Amgen Q4 2022 revenue was up 3% y/y. Cancer therapy Lumakras is a new revenue driver.
